Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment
Abstract Introduction: Matrix metalloproteinases (MMPs) are classified in the family of zinc-
dependent endopeptidases, which can degrade various components of an extracellular …
dependent endopeptidases, which can degrade various components of an extracellular …
Matrixmetalloproteinase inhibitors: promising therapeutic targets against cancer
V Rani, D Yadav, N Atale - Current pharmaceutical design, 2021 - ingentaconnect.com
Background: Cancer is a wide range cellular level disease that occurs when cells go
through uncontrolled division and growth. The mechanisms by which the cells undergo …
through uncontrolled division and growth. The mechanisms by which the cells undergo …
Matrix metalloproteinase inhibitors as anticancer therapeutics
F Mannello, G Tonti, S Papa - Current cancer drug targets, 2005 - ingentaconnect.com
Matrix metalloproteinases (MMPs), also designated as matrixins, play a central role in many
biological processes and are involved both in physiologic cellular processes and in …
biological processes and are involved both in physiologic cellular processes and in …
Matrix metalloproteinase inhibitors as anticancer agents
PA Konstantinopoulos, MV Karamouzis… - The international journal …, 2008 - Elsevier
The important role of matrix metalloproteinases (MMPs) in the process of carcinogenesis is
well established. However, despite very promising activity in a plethora of preclinical …
well established. However, despite very promising activity in a plethora of preclinical …
[图书][B] Matrix metalloproteinase inhibitors in cancer therapy
NJ Clendeninn, K Appelt - 2000 - books.google.com
Cutting-edge investigators review the current status of the entire field, from the biology of
MMPs through the current clinical studies. The authors include many leading scientists from …
MMPs through the current clinical studies. The authors include many leading scientists from …
Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer
Y Zhong, YT Lu, Y Sun, ZH Shi, NG Li… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: The overexpression of matrix metalloproteinase (MMP) plays an important role
in the context of tumor invasion and metastasis, and MMP-2 has been characterized as the …
in the context of tumor invasion and metastasis, and MMP-2 has been characterized as the …
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Matrix metalloproteinases (MMPs) consist of a multigene family of zinc‐dependent
extracellular matrix (ECM) remodeling endopeptidases implicated in pathological …
extracellular matrix (ECM) remodeling endopeptidases implicated in pathological …
Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects
B Fingleton - Expert opinion on therapeutic targets, 2003 - Taylor & Francis
Inhibition of matrix metalloproteinases (MMPs), a family of proteolytic enzymes linked to
many aspects of cancer progression, has been explored as a therapeutic goal for almost two …
many aspects of cancer progression, has been explored as a therapeutic goal for almost two …
Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes
A Winer, S Adams, P Mignatti - Molecular cancer therapeutics, 2018 - AACR
The matrix metalloproteinases (MMP) are a family of proteolytic enzymes that degrade
multiple components of the extracellular matrix. A large body of experimental and clinical …
multiple components of the extracellular matrix. A large body of experimental and clinical …
Matrix metalloproteinases inhibitors in cancer treatment: an updated review (2013–2023)
Matrix metalloproteinases (MMPs) are identifiable members of proteolytic enzymes that can
degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be …
degrade a wide range of proteins in the extracellular matrix (ECM). MMPs can be …
相关搜索
- matrix metalloproteinase inhibitors
- pharmacodynamic considerations cancer treatment
- metalloproteinase inhibitors anticancer therapeutics
- matrixmetalloproteinase inhibitors therapeutic targets
- cancer management matrix metalloproteinases
- cancer progression matrix metalloproteinases
- challenging paradigm matrix metalloproteinases